Main menu

2007 Financial Report

Financial Report 2007

This Information is Intended for Investors

cov 1 (1 of


Financial Review
   Overview of Our Performance and Operating Environment
   Accounting Policies
   Analysis of the Consolidated Statement of Income
   Revenues - Major Pharmaceutical Products
   Animal Health
   Costs and Expenses
   Adjusted Income
   Financial Condition, Liquidity and Capital Resources
   New Accounting Standards
   Management's Report on Internal Control Audit Committee's Report Over Financial Reporting
   Report of Independent Registered Public Accounting Firm on the Consolidated Financial Statements
   Internal Control Over Financial Reporting
Consolidated Statements of Income
Consolidated Balance Sheets
Consolidated Statements of Shareholders' Equity
Consolidated Statements of Cash Flows
Notes to Consolidated Financial Statements
   Note 1 - Significant Accounting Policies
   Note 2 - Acquisitions
   Note 3 - Discontinued Operations
   Note 4 - Asset Impairment Charges and Other Costs Associated with Exiting Exubera
   Note 5 - Cost-Reduction Initiatives
   Note 6 - Acquisition-Related Costs
   Note 7 - Other (Income)/Deductions-Net
   Note 8 - Taxes on Income
   Note 9 - Other Comprehensive Income/(Expense)
   Note 10 - Financial Instruments
   Note 11 - Inventories
   Note 12 - Property, Plant and Equipment
   Note 13 - Goodwill and Other Intangible Assets
   Note 14 - Pension and Postretirement Benefit Plans and Defined Contribution Plans
   Note 15 - Equity
   Note 16 - Share-Based Payments
   Note 17 - Earnings per Common Share
   Note 18 - Earnings per Common Share
   Note 19 - Insurance
   Note 20 - Legal Proceedings and Contingencies
   Note 21 - Segment, Geographic and Revenue Information
Quarterly Consolidated Financial Data (Unaudited) 2007
Quarterly Consolidated Financial Data (Unaudited) 2006
Financial Summary
Peer Group Performance Graph
cov 1 (1 of